Ari Lewenstein

Title: Ari Lewenstein: Innovator in Pharmaceutical Compositions

Introduction

Ari Lewenstein is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the modulation of immune reactions. With a total of 2 patents, his work focuses on innovative compositions that can enhance the treatment of various diseases.

Latest Patents

Lewenstein's latest patents include a pharmaceutical composition and method for modulating the immune reaction. This patent describes pharmaceutical compositions for the modulation of the immune reaction of warm-blooded animals, which are derivatives of 2-oxindole-3-acetic acid or 2-oxo-1,2,3,4-tetrahydroquinoline-4-carboxylic acid. The derivatives can exist in equilibrium with each other and include both previously described compounds and new compounds. Additionally, he has developed new derivatives of these acids, particularly the pure antipodes of the mixture of enantiomers of the 2-oxo-1,2,3,4-tetrahydroquinoline-4-carboxylic acid. Another patent focuses on glucosides isolated from pollen and their sugar-free decomposition products. These novel glucosides and their derivatives can be used as active components in pharmaceutical compositions for treating tumors and virus-related diseases.

Career Highlights

Ari Lewenstein is associated with Cerbios-Pharma SA, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing new therapeutic options that can significantly impact patient care.

Collaborations

Some of his notable coworkers include Jean-Claude Jaton and Fabrizio Marazza, who contribute to the collaborative efforts in research and development at Cerbios-Pharma SA.

Conclusion

Ari Lewenstein's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of immune modulation and the potential for new treatments in healthcare.